Toronto-Dominion, Bombardier, Enbridge, Valeant: Canadian Equity Preview

Shares of the following companies may have unusual moves in Canadian trading. Stock symbols are in parentheses.

Bombardier Inc. (BBD/B CT): The world’s third-biggest civil-aircraft manufacturer posted third-quarter earnings excluding some items of 8 cents a share, missing the average analyst estimate in a Bloomberg survey by a penny.

Canadian Imperial Bank of Commerce (CM CT): Canada’s fifth- largest bank by assets reported fourth-quarter profit that fell 22 percent to C$500 million, or C$1.17 a share.

Enbridge Inc. (ENB CT): Canada’s largest pipeline company raised its quarterly dividend by 15 percent to 49 cents a share as of the dividend payable on March 1.

Gildan Activewear Inc. (GIL CT): The clothing maker with operations in the U.S., Haiti and Central America initiated a quarterly dividend of 7.5 cents a share and said it intends to buy back up to 1 million shares.

SXC Health Solutions Corp. (SXC CT): The provider of pharmacy benefit management services and health-care information technology said it agreed to buy MedfusionRx LLC for $100 million in cash.

Talisman Energy Inc. (TLM CT): The Calgary-based oil and gas company got a C$3.85 billion ($3.78 billion) revolving line of credit for general corporate purposes, according to a person familiar with the deal.

Toronto-Dominion Bank (TD CT): The country’s second-biggest bank reported fourth-quarter profit of C$1.38 a share, missing the average profit estimate among 16 analysts in a Bloomberg survey of C$1.46 a share, excluding certain items.

Valeant Pharmaceuticals International Inc. (VRX CT): Canada’s largest drugmaker said the U.S. Food and Drug Administration declined to approve ezogabine, an epilepsy medicine developed with GlaxoSmithKline Plc, in its current form. The companies said they believe the FDA’s concerns can be addressed.

Viterra Inc. (VT CT): Canada’s biggest grain handler announced an annual dividend of C$0.10 a share.

To contact the reporter on this story: Inyoung Hwang at ihwang7@blooomberg.net.

To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.